Determination of Remifentanil's ED50 for Rapid Sequence Intubation Avoiding Bradycardia and Hypotension in Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 25, 2017

Primary Completion Date

February 28, 2017

Study Completion Date

March 1, 2017

Conditions
BradycardiaHypotension
Interventions
DRUG

Remifentanil

bolus dose

Trial Locations (1)

70000000

Hospital das Forças Armadas, Brasília

All Listed Sponsors
lead

Brasilia University Hospital

OTHER

NCT03065309 - Determination of Remifentanil's ED50 for Rapid Sequence Intubation Avoiding Bradycardia and Hypotension in Adults | Biotech Hunter | Biotech Hunter